Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jan Tavernier"'
Autor:
Jacques De Keyser, Sarah Gerlo, Guy Laureys, Krzysztof Kolmus, Jan Tavernier, Joeri L. Aerts, Anneleen Spooren
Publikováno v:
Cytokine. 76:98
β 2-adrenergic receptor ( β 2-AR) agonists are widely applied in the clinic for treatment of respiratory disease. Although their therapeutic effect mainly results from their spasmolytic activity, β -agonists have also been attributed with anti-inf
Publikováno v:
Journal of Allergy and Clinical Immunology. 87:339
Autor:
Frans Van Roy, Xavier Van Ostade, Peter Brouckaert, Bart Everaerdt, Walter Fiers, Rudi Beyaert, Philip Noel Suffys, Peter Vandenabeele, Bart Vanhaesebroeck, Guy Haegeman, Jan Tavernier
Publikováno v:
Immunology Letters. 16:219-226
The genes for a number of proteins, potentially useful in cancer therapy and collectively called "biological response modifiers", have been cloned and expressed in micro-organisms in recent years. These recombinant proteins, which are now available i
Autor:
D C Talbot, Richard H. Osborne, Jan Tavernier, Helga Durbin, Frances R. Balkwill, Stuart Naylor, Walter Fiers, Frances Burke
Publikováno v:
The Lancet. 330:1229-1232
Labile tumour-necrosis-factor-like (TNF) activity was detected by means of an enzyme-linked immunosorbent assay in 50% of 226 freshly obtained serum samples from cancer patients with active disease. In contrast, only 3% of 32 samples from normal subj